BDNF Actions in the Cardiovascular System: Roles in Development, Adulthood and Response to Injury

The actions of BDNF (Brain-derived Neurotrophic Factor) in regulating neuronal development and modulating synaptic activity have been extensively studied and well established. Equally important roles for this growth factor have been uncovered in the cardiovascular system, through the examination of gene targeted animals to define critical actions in development, and to the unexpected roles of BDNF in modulating the response of the heart and vasculature to injury. Here we review the compartmentally distinct realm of cardiac myocytes, vascular smooth muscle cells, endothelial cells, and hematopoietic cells, focusing upon the actions of BDNF to modulate contractility, migration, neoangiogenesis, apoptosis and survival. These studies indicate that BDNF is an important growth factor which directs the response of the cardiovascular system to acute and chronic injury.

[1]  M. Vilar,et al.  Neurotrophins and Neurotrophin Receptors , 2020 .

[2]  C. Liston,et al.  The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior , 2018, Neuron.

[3]  C. Liston,et al.  The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior , 2018, Neuron.

[4]  P. Lazarovici,et al.  Nerve Growth Factor-Induced Angiogenesis: 1. Endothelial Cell Tube Formation Assay. , 2018, Methods in molecular biology.

[5]  Svati H Shah,et al.  Brain‐derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort , 2017, American heart journal.

[6]  N. Unsain,et al.  Growth factors and hormones pro‐peptides: the unexpected adventures of the BDNF prodomain , 2017, Journal of neurochemistry.

[7]  L. McCullough,et al.  Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery , 2016, Pharmacology Biochemistry and Behavior.

[8]  Y. Barde,et al.  Brain-derived Neurotrophic Factor in Megakaryocytes*♦ , 2016, The Journal of Biological Chemistry.

[9]  C. Glatt,et al.  Common Polymorphisms in the Age of Research Domain Criteria (RDoC): Integration and Translation , 2016, Biological Psychiatry.

[10]  N. Pivac,et al.  A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease. , 2016, European review for medical and pharmacological sciences.

[11]  L. Tessarollo,et al.  BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activation , 2015, The Journal of cell biology.

[12]  S. Yamawaki,et al.  BDNF pro-peptide actions facilitate hippocampal LTD and are altered by the common BDNF polymorphism Val66Met , 2015, Proceedings of the National Academy of Sciences.

[13]  Z. Du,et al.  Brain-Derived Neurotrophic Factor Regulates TRPC3/6 Channels and Protects Against Myocardial Infarction in Rodents , 2015, International journal of biological sciences.

[14]  D. Kass,et al.  Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation , 2015, Autonomic Neuroscience.

[15]  M. Chao,et al.  Shaping neurons: Long and short range effects of mature and proBDNF signalling upon neuronal structure , 2014, Neuropharmacology.

[16]  S. Rafii,et al.  Trkb Signaling in Pericytes Is Required for Cardiac Microvessel Stabilization , 2014, PloS one.

[17]  B. Lu,et al.  BDNF and synaptic plasticity, cognitive function, and dysfunction. , 2014, Handbook of experimental pharmacology.

[18]  B. Hempstead.  Deciphering proneurotrophin actions. , 2014, Handbook of experimental pharmacology.

[19]  F. Lee,et al.  Val66Met Polymorphism of BDNF Alters Prodomain Structure to Induce Neuronal Growth Cone Retraction , 2013, Nature Communications.

[20]  D. Katz,et al.  Neurotrophic factors in development and regulation of respiratory control. , 2013, Comprehensive Physiology.

[21]  J. Hensler,et al.  Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice , 2013, American journal of physiology. Heart and circulatory physiology.

[22]  Ziqiang Yuan,et al.  BDNF-mediated migration of cardiac microvascular endothelial cells is impaired during ageing , 2012, Journal of cellular and molecular medicine.

[23]  C. Siao,et al.  ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation , 2012, The Journal of experimental medicine.

[24]  I. Komuro,et al.  Brain-Derived Neurotrophic Factor Protects Against Cardiac Dysfunction After Myocardial Infarction via a Central Nervous System–Mediated Pathway , 2012, Arteriosclerosis, Thrombosis and Vascular Biology.

[25]  G. Norata,et al.  Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse. , 2012, Biochimica et biophysica acta.

[26]  D. Wagner,et al.  ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Yunyu Zhang,et al.  TrkB agonist antibody dose-dependently raises blood pressure in mice with diet-induced obesity. , 2010, American journal of hypertension.

[28]  D. Bates,et al.  Neurotrophin-3 Is a Novel Angiogenic Factor Capable of Therapeutic Neovascularization in a Mouse Model of Limb Ischemia , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[29]  C. Lagrasta,et al.  Nerve Growth Factor Promotes Cardiac Repair following Myocardial Infarction , 2010, Circulation research.

[30]  J. Luther,et al.  Neurotrophins and target interactions in the development and regulation of sympathetic neuron electrical and synaptic properties , 2009, Autonomic Neuroscience.

[31]  Ying Liu,et al.  Application of bFGF and BDNF to improve angiogenesis and cardiac function. , 2006, The Journal of surgical research.

[32]  J. Bella,et al.  BDNF-mediated enhancement of inflammation and injury in the aging heart. , 2006, Physiological genomics.

[33]  G. Sobue,et al.  Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75ngfr, TrkA, TrkB, and TrkC) in the adult human peripheral nervous system and nonneural tissues , 1996, Neurochemical Research.

[34]  K. Kent,et al.  Decreased Neurotrophin TrkB Receptor Expression Reduces Lesion Size in the Apolipoprotein E–Null Mutant Mouse , 2005, Circulation.

[35]  Holger Scholz,et al.  Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. , 2005, Genes & development.

[36]  Barbara L. Hempstead,et al.  ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTR and Sortilin , 2005, The Journal of Neuroscience.

[37]  S. Rafii,et al.  Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. , 2005, The Journal of clinical investigation.

[38]  Paresh D Patel,et al.  Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons , 2004, The Journal of Neuroscience.

[39]  L. Tessarollo,et al.  Neural crest stem cell and cardiac endothelium defects in the TrkC null mouse , 2003, Molecular and Cellular Neuroscience.

[40]  R. Kraemer.  Reduced Apoptosis and Increased Lesion Development in the Flow-Restricted Carotid Artery of p75NTR-Null Mutant Mice , 2002, Circulation research.

[41]  S. Meri,et al.  Nerve growth factor and brain‐derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion , 2001, The Journal of pathology.

[42]  S. Rafii,et al.  Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. , 2000, Development.

[43]  T. Mikawa,et al.  Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo. , 2000, Developmental biology.

[44]  Jess Li,et al.  Vascular endothelial cells synthesize and secrete brain‐derived neurotrophic factor , 2000, FEBS letters.

[45]  Y. Nakamura,et al.  Gene expression of neurotrophins and their receptors in cultured rat vascular smooth muscle cells. , 1998, Biochemical and biophysical research communications.

[46]  L. Tessarollo,et al.  Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Saarma,et al.  Expression of mRNAs for neurotrophins and their receptors in developing rat heart. , 1996, Circulation research.

[48]  L. Tessarollo,et al.  Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development , 1996, Nature Genetics.

[49]  S. Radka,et al.  Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay , 1996, Brain Research.

[50]  Michael J. O'Donovan,et al.  Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. , 1995, The American journal of pathology.

[51]  M. Barbacid.  The Trk family of neurotrophin receptors. , 1994, Journal of neurobiology.

[52]  E. Jones,et al.  Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  H. Thoenen,et al.  Purification of a new neurotrophic factor from mammalian brain. , 1982, The EMBO journal.

[54]  R. Levi‐montalcini,et al.  Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein* , 1960, Proceedings of the National Academy of Sciences.